SPINRAZA 2.4 MG
NUSINERSEN (NUSINERSEN SODIUM) : 2.4 MG · DIN 02465663 · BIOGEN CANADA INC
Health Canada status: MARKETED
What is SPINRAZA?
SPINRAZA 2.4 MG contains NUSINERSEN (NUSINERSEN SODIUM) : 2.4 MG. It is listed in the Health Canada Drug Product Database under DIN 02465663, held by BIOGEN CANADA INC, supplied as SOLUTION for INTRATHECAL administration. Health Canada currently lists it as marketed, status dated 29-Aug-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is SPINRAZA used for?
SPINRAZA (nusinersen) is indicated for the treatment of 5q Spinal Muscular Atrophy (SMA). There are limited data in patients over the age of 18 years. SPINRAZA has been studied in patients ranging in age from newborn to 19 years.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02465663 |
|---|---|
| Brand name | SPINRAZA |
| Generic / active ingredient | NUSINERSEN (NUSINERSEN SODIUM) : 2.4 MG |
| Manufacturer | BIOGEN CANADA INC |
| Strength | 2.4 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRATHECAL |
| Schedule | Prescription |
| ATC code | M09AX07 NUSINERSEN |
| AHFS class | 92:18.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 29-Aug-2017 |
| Original market date | 2017-08-29 00:00:00 |
How is it stored and handled?
The vial should be taken out of the refrigerator and allowed to warm to room temperature (25 o C/77 o F) without using external heat sources, prior to administration.
How is it supplied?
one vial per carton.
Who else supplies NUSINERSEN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. NUSINERSEN appears in 35 registered pack listings across 10 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.